Bayou Surgical

Coming – May 28

Maximum Impact On Minimally Invasive Surgery

Date and Time

May 28

–

4:00 PM ET / 1:00 PM PT

Details will be provided upon RSVP approval

About this Event

Bayou Surgical has developed troCarWash™, a lens cleaning platform that is redefining visualization in minimally invasive surgery. The product is best-in-class and purpose-built for both laparoscopic and robotic procedures.

In minimally invasive surgery, visualization is everything. Yet the NIH estimates surgeons lose clear sight 37% of the time due to lens contamination which forces repeated interruptions to remove and clean the scope, disrupting workflow, increasing costs, and introducing risk.

troCarWash is the only automated solution that cleans the lens without removing it from the body, restoring visibility in the blink of an eye and maintaining procedural continuity. By reducing interruptions, the system has the potential to shorten operating times, improve outcomes, and drive meaningful cost savings for hospitals.

With 15 million laparoscopic procedures performed in the U.S. each year and a $4.5B global market, the addressable market is both large and highly repeatable.

Join our Fireside Chat with Bayou Surgical CEO, Sharad Joshi, to hear how the company reports building a $3.8 million qualified pipeline with just three part-time sales representatives and gaining significant interest from strategics in less than a year.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.